Please login to the form below

Not currently logged in
Email:
Password:

Patrick Vallance

This page shows the latest Patrick Vallance news and features for those working in and with pharma, biotech and healthcare.

GSK’s vaccines president Debruyne heads for the exit

GSK’s vaccines president Debruyne heads for the exit

Following in the footsteps of former chief executive Sir Andrew Witty - who left the company in March last year - R&D head Patrick Vallance also jolted for the exit, along with

Latest news

More from news
Approximately 2 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics